DRDO responds to questions on 2-DG’s efficacy; Also launches Antibody Detection Kit for COVID-19
It went on to state the molecule was working effectively against SARS-CoV-2 virus, and inhibited the viral growth. Last May, Drugs Controller General of India’s (DCGI) and Central Drugs Standard Control Organization (CDSCO) had approved the Phase-II clinical trial of 2-DG in COVID-19 patients. (Photo Credit : DRDO) Amidst debate over the efficacy of the … Read more